Target intelligence / Profile preview

Ribosomal protein L18 pseudogene 13 (RPL18P13)

Target: RPL18P13
Molecular classification: Other (pseudogene), Ribosomal protein pseudogene

Overview

Ribosomal protein L18 pseudogene 13 (RPL18P13) is a human pseudogene related to the ribosomal protein L18. It does not encode a functional protein and is classified among ribosomal protein pseudogenes, which are non-coding segments of DNA similar to genes encoding ribosomal proteins. While ribosomal proteins themselves play essential roles in the formation and function of ribosomes (cellular complexes responsible for protein synthesis), pseudogenes such as RPL18P13 are generally considered functionally inert. The biological significance of ribosomal protein pseudogenes may include contributions to genomic structural variation or roles as non-coding RNAs in regulation, but there is no published evidence to suggest any functional or disease associations for RPL18P13 specifically.

Other names: RPL18_5_1500RPL18P13

Mechanism of action

None applicable, as no drugs interact with this pseudogene

Biological functions

Other (as a pseudogene, no protein-coding biological function)Ribosomal protein pseudogenes may impact gene regulation through non-coding RNA activity, but there is no direct evidence for RPL18P13 specifically

Disease associations

None established. There are no reported roles of RPL18P13 in diseases or as biomarkers for any condition. For some other ribosomal pseudogenes, associations with cellular proliferation and tumor tissue have been described, but not for RPL18P13 specifically

Safety considerations

None reported. Safety concerns are not relevant as RPL18P13 is not a druggable protein or therapeutic target

Interacting drugs

None reported. There are no drugs known to target RPL18P13

Biomarkers

None established. RPL18P13 is not used as a biomarker for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Ribosomal protein L18 pseudogene 13 (RPL18P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L18 pseudogene 13 (RPL18P13).

Explore the full profile